← Back to list
Neuroablative Techniques for Chronic Pain - Medicare Advantage (Revised)
Effective date
Aug 6, 2026
Identified
Aug 4, 2026
Replaced. This version was replaced by Neuroablative Techniques for Chronic Pain - Medicare Advantage (Revised) (effective Nov 1, 2026).
Summary
This is a comprehensive Medicare Advantage coverage policy for neuroablative techniques used to treat chronic pain, effective 08/06/2026. The policy defines coverage criteria, eligible procedures (including radiofrequency ablation, cryoablation, chemical neurolysis, and specialized devices like Intracept), and references MAC-specific LCDs and billing codes by geographic jurisdiction. Billing teams must verify applicable MAC guidelines for their state and ensure claims comply with local coverage determinations.
Get alerts when payers change rules like this one
We check Humana and other payers every day and email you when a change matches your specialty and state.
Get Humana alertsPolicy Monitoring is free. No card required.
What to do
Action · 7 steps
01By 08/06/2026: Billing team must obtain and implement the applicable MAC Local Coverage Determination (LCD) and Local Coverage Article (LCA) for your geographic jurisdiction from the table on pages 2-3.
02Identify your state and corresponding MAC contractor (e.g., J5 for Wisconsin, J6 for Illinois/Minnesota/Wisconsin, JE/JF for West Coast).
03Download the specific LCD/LCA documents referenced (e.g., L38841, A58477 for Facet Joint Interventions) from the CMS Medicare Coverage Database.
04Update billing software, charge capture systems, and provider documentation templates to reflect coverage limitations and coding requirements specific to your MAC.
05Train billing staff on neuroablative procedure codes and prior authorization requirements per your MAC's guidelines.
06Verify that all neuroablative claims (radiofrequency ablation, cryotherapy, chemical neurolysis, Intracept, iovera) submitted on or after 08/06/2026 comply with your MAC's LCD.
07Establish internal protocols to verify medical necessity documentation for denervation procedures.
If missed: Failure to apply correct MAC guidelines will result in claim denials and recoupment.
Original notice
Neuroablative Techniques for Chronic Pain - Medicare Advantage (Revised)
mcp.humana.com · Always check the source before changing claims.
Related changes
See all Humana changes →Neuroablative Techniques for Chronic Pain - Medicare Advantage (Revised)MediumEffective Nov 1, 2026 · Medicare AdvantageNeuroablative Techniques for Chronic Pain - Medicare Advantage (Revised)MediumEffective Oct 25, 2026 · Medicare AdvantageNeuroablative Techniques for Chronic Pain - Medicare Advantage (Revised)HighEffective Aug 6, 2026 · Medicare AdvantageNeuroablative Techniques for Chronic Pain - Medicare Advantage (Revised)HighNo effective date · Medicare AdvantageBrowse every Humana change in the policy list
Related policy hubs
Humana policiesIA policy changesKS policy changesMO policy changesNE policy changesIN policy changesMI policy changesIL policy changesMN policy changesWI policy changesCT policy changesMA policy changesME policy changesNH policy changesNY policy changesRI policy changesVT policy changesKY policy changesOH policy changesCA policy changesHI policy changesNV policy changesAK policy changesAZ policy changesID policy changesMT policy changesND policy changesOR policy changesSD policy changesUT policy changesWA policy changesWY policy changesAR policy changesCO policy changesLA policy changesMS policy changesNM policy changesOK policy changesTX policy changesDE policy changesDC policy changesMD policy changesNJ policy changesPA policy changesAL policy changesGA policy changesTN policy changesNC policy changesSC policy changesVA policy changesWV policy changesFL policy changesPR policy changesPain ManagementNeurosurgeryOrthopedicsAnesthesiology